Adoptively transferred EAE in mice bearing the lpr mutation

Clinical Immunology and Immunopathology

Volumn 85, Issue 3, 1997, Pages 315-319

  Clark, Robert B ^a   Grunnet, Margaret ^a   Lingenheld, Elizabeth G ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAS ANTIGEN; FAS LIGAND; GENE PRODUCT;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CENTRAL NERVOUS SYSTEM; FEMALE; GENE; GENE MUTATION; HISTOPATHOLOGY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 17344392744     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4450     Document Type: Article

References (13)

1. Ferber I. A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Fathman C. G. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:1996;5-7.
2. Koh D., Ho A., Rahemtulla A., Penninger J., Mak T. Experimental allergic encephalomyelitis in mice lacking CD4+ T cells. Eur. J. Immunol. 24:1994;2250.
3. Grewal I. S., Foellmer H. G., Grewal K. D., Xu J., Hardardottir F., Baron J. L., Janeway C. A., Flavell R. A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864.
4. Elliot E. A., McFarland H. I., Nye S. H., Cofiell R., Wilson T. M., Wilkins J. A., Squinto S. P., Matis L. A., Mueller J. P. Treatment of experimental allergic encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1996;1602-1612.
5. Merrill J., Kono D., Clayton J., Ando D., Hinton D., Hofman F. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:1992;574-579.
6. Kuchroo U. K., Martin C. A., Greer J. M., Ju S. T., Sobel R. A., Dorf M. E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
7. Beraud E., Balzano C., Zamora A. J., Bernard D., Ben-Nun A. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: Functional characteristics and vaccination properties. J. Neuroimmunol. 47:1993;41-53.
8. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
9. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
10. Padula S. J., Lingenheld E. G., Stabach P. R., Chou C-H. J., Kono D. H., Clark R. B. Identification of encephalitogenic V-4-bearing T cells in SJL mice. Further evidence for the V-region disease hypothesis? J. Immunol. 146:1991;879-883.
11. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
12. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314-317.
13. Lynch D. H., Ramsdell F., Alderson M. R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.